• TCGA study of liver cancer reveals potential targets for therapy Thu, Jun 15 2017

    Only two drugs are FDA-approved for liver cancer. This study of hepatocellular carcinoma found genetic alterations in tumors—including mutations in tumor-suppressing genes and high expression of immune checkpoint genes—that could be targets for drugs that already exist.

  • Study estimates number of U.S. women living with metastatic breast cancer Thu, May 18 2017

    A new study shows that the number of women in the United States living with distant metastatic breast cancer (MBC), the most severe form of the disease, is growing. This is likely due to the aging of the U.S. population and improvements in treatment.